NTLA
Intellia Therapeutics, Inc.Company with tickers: NTLA
CIK
1652130
CUSIP
45826J105
Shares Outstanding
139,722,277
Website
https://www.intelliatx.com
13F Activity (30d)
6 filings
5 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-11 | LEONARD JOHN M | Officer, Director | 88,146 | 2025-12-11 | UBS Financial Services, Inc. |
| 2024-01-08 | Sepp-Lorenzino Laura | Officer | 2,275 | 2024-01-08 | UBS Financial Services, Inc. |
| 2023-12-07 | John F. Crowley | Former Director | 32,791 | 2023-12-06 | E*Trade Financial Corporation |
| 2023-07-31 | MUNA BHANJI | Director | 265 | 2023-07-31 | E*TRADE FINANCIAL CORPORATION |
| 2023-07-06 | MUNA BHANJI | Director | 1,867 | 2023-07-06 | E*TRADE FINANCIAL CORPORATION |
| 2023-06-20 | ELIANA CLARK | Officer | 5,000 | 2023-06-20 | E*TRADE FINANCIAL CORPORATION |
Showing 1–6 of 6 filings